Truveta: EHR Data Company Raises $320 Million At Over $1 Billion Valuation
By Amit Chowdhry ● Today at 4:04 PM
Leading US health systems, including Advocate Health, CommonSpirit Health, Henry Ford Health, Northwell Health, Providence, and Trinity Health, announced the Truveta Genome Project, which is an innovative collaboration to generate genetic data on tens of millions of consented and de-identified volunteers, creating the largest and most diverse database of genotypic and phenotypic information ever assembled. For this initiative, 17 health systems, including Regeneron and Illumina, have invested $320 million in Truveta preferred equity at a valuation exceeding $1 billion. As part of this deal, Regeneron has made a strategic investment of $119.5 million upfront (as part of Truveta’s Series C financing round), enabling the advancement of discovery and development of new therapies and the development of next-generation solutions for healthcare delivery and population health management. And Illumina, a global leader in DNA sequencing and array-based technologies, will invest $20 million. This builds on the previously announced strategic investment Microsoft made into Truveta.